{
    "key_points": [
        "As of March 1, about 50 million U.S. residents had received at least one dose of a COVID-19 vaccine.",
        "A Kaiser Family Foundation poll found that 44% of U.S. adults were hesitant about getting vaccinated.",
        "Experts estimate 80% to 85% of the population needs immunity to end the pandemic.",
        "Concerns exist about the vaccines' safety, efficacy, especially regarding new variants, and potential side effects.",
        "Clinical trials and real-world data show vaccines are safe, with rare cases of anaphylaxis treatable.",
        "Vaccines are effective in reducing virus transmission, including asymptomatic transmission.",
        "People who have had COVID-19 are still advised to get vaccinated for better protection.",
        "Current vaccines are effective against variants, with ongoing monitoring for any that may evade vaccine protection.",
        "Vaccination, coupled with public health measures, can lead to a return to normal activities.",
        "Scientists are optimistic that emerging variants can be managed and vaccines adjusted if necessary."
    ],
    "spokespersons": [
        "Monica Gandhi (Professor of Medicine, Associate Division Chief, Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco at Zuckerberg San Francisco General Hospital and Trauma Center)",
        "Megan Ranney (Emergency Medicine Physician, Founding Director, Brown-Lifespan Center for Digital Health, Brown University)",
        "Alessandro Sette (Immunologist, La Jolla Institute for Immunology)",
        "Matthew Frieman (Associate Professor of Microbiology and Immunology, University of Maryland School of Medicine)"
    ],
    "article_type": "general reporting",
    "dateline": "",
    "audience": "general public",
    "stance": "neutral"
}